Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/7/26 18:36 | 10/5/26 | GRAL | Health | Health | Medical Laboratories | Partridge Andrew John | CA | O | Chief Gr | 1 | S | -1,153 | 146.39 | 0 | -8 | 156 | D | |||||||||||||||
10/7/26 18:36 | 10/5/26 | GRAL | Health | Health | Medical Laboratories | Freidin Aaron | CA | O | CFO | 3 | S | -4,512 | 126.67 | 0 | -36 | 253 | D | |||||||||||||||
9/23/26 16:37 | 9/21/26 | GRAL | Health | Health | Medical Laboratories | Ofman Joshua J. | CA | DO | CEO | 3 | M.d | 6,802 | 73.21 | 0 | 93 | 31 | 397 | D | ||||||||||||||
9/23/26 16:37 | 9/21/26 | GRAL | Health | Health | Medical Laboratories | Ofman Joshua J. | CA | DO | CEO | 3 | S.d | -6,802 | 73.21 | 0 | -93 | 397 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |